XML 12 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 9 Months Ended
Jun. 30, 2017
Aug. 18, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name American BriVision (Holding) Corp  
Entity Central Index Key 0001173313  
Amendment Flag true  
Amendment Description

Explanatory Note

 

American BriVision (Holding) Corporation (together with its subsidiary, the “Company” sometimes referred to as “we”, “us” or “our”) is filing this Amendment No. 1 (this “Amendment No.1” or “Form 10-Q/A”) to its Quarterly Report on Form 10-Q for the period ended June 30, 2017, originally filed on August 21, 2017, (the “Original Form 10-Q”) to reflect the restatement of its consolidated financial statements for the period ended June 30, 2017, and related disclosures described below. The restatement of the Original Form 10-Q reflected in this Amendment No.1 corrects revenue, gross profit, net loss from operations, loss from continuing operations before income taxes, and net loss for the three and nine months ended June 30, 2017, additional paid-in capital and accumulated deficit as of June 30, 2017, and the disclosures of related party transaction (see Note 6) and earnings per share (see Note 9) for the three and nine months ended June 30, 2017. There is no impact or changes to the total assets, total liability and total stockholders’ equity as of June 30, 2017. For details of the changes, please refer to Note 2 of the consolidated financial statements.

 

No other sections were affected, but for the convenience of the reader, this report on Form 10-Q Amendment No. 1 restates in its entirety, as amended, our Original Form 10-Q.

 

This report on Form 10- Q Amendment No.1 is presented as of the filing date of the Original Form 10-Q and does not reflect events occurring subsequent to the date of filing of the Original Form 10-Q.

 

Background of Restatements in Amendment No.1

 

The additional paid-in capital and accumulated deficit as of June 30, 2017 was erroneously stated as $10,586,464 and $(11,848,288), respectively, on the Original Form 10-Q. The Company restated the additional paid-in capital and accumulated deficit as of June 30, 2017 as $10,746,464 and $(12,008,288), respectively. The error as a result of related party under common control transactions caused $160,000 difference in both accounts. There is no impact on the ending balance of the total stockholders’ equity as of June 30, 2017. The Company also restated revenue, gross profit, net loss from operations, loss from continuing operations before income taxes, and net loss in its statements of operation for the three and nine months ended June 30, 2017 for the same reason.

 

On the Notes 6 to Consolidated Financial Statements of the Original Form 10-Q, the Company recorded revenues of $160,000, of which $70,000 was attributable to a consulting service provided to a Company’s shareholder, LionGene Corporation and $90,000 was as a result of the co-development with related party, Rgene Corporation (see Note 5 and Note 6). The Company determined that the total amount of $160,000 should be recorded as additional paid-in capital since the Company, LionGene Corporation, and Rgene Corporation are related parties and under common control by a controlling beneficiary shareholder of YuanGene Corporation, and should be treated as the correction of error as of June 30, 2017.

 

On the Notes 9 to Consolidated Financial Statements of the Original Form 10-Q, the net loss in the disclosure of the earning per share for the three and nine months ended June 30, 2017 was erroneously reflected as $(127,879) and $(524,887), respectively. The earning-per-share on the Original Form 10-Q for the three and nine months ended June 30, 2017 was $(0.00060) and $(0.00247), respectively, which were recorded as $(0.00) and $(0.00). The Company corrected the net loss in the disclosure of the earning per share for the three and nine months ended June 30, 2017 to $(217,879) and $(684,887), respectively in order to align with the net loss and weight-average shares outstanding basic and diluted as reflected on the accompanying unaudited Condensed Consolidated Statements of Operations for the three and nine months ended June 30, 2017. The corrected earning per share was $(0.00102) and $(0.00323), respectively, which are shown as $(0.00) and $(0.00). The overall impact in the earning-per-share for the three and nine months ended June 30, 2017 is $(0.00042) and $(0.00076), respectively.

 

Items Amended by the Amendment No.1

 

This Amendment reflects the results of the work described above and includes the restatement of our consolidated financial statements for the period ended June 30, 2017. For the convenience of the reader, this Amendment sets forth the Original Form 10-Q, as modified and superseded where necessary to reflect the restatement and other related adjustments, internal control matters, and as otherwise specifically indicated. Specifically, the following items included in the Original Form 10-Q are amended by this Amendment:

 

- Part I, Item 1, Financial Statements

 

- Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operation

  
Trading Symbol MTOO  
Current Fiscal Year End Date --09-30  
Document Type 10-Q  
Document Period End Date Jun. 30, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   213,746,647